INTELLECTUAL PROPERTY SECURITY AGREEMENT
----------------------------------------
INTELLECTUAL PROPERTY SECURITY AGREEMENT, dated as of May 17, 1999,
between Premier Laser Systems, Inc., a California corporation ("Premier"), and
the secured parties signatory hereto, and their respective endorsees,
transferees and assigns (collectively the "Secured Party").
W I T N E S S E T H:
- - - - - - - - - -
WHEREAS, pursuant to a Secured Convertible Debenture Purchase
Agreement, dated the date hereof among Premier and the Secured Party (the
"PURCHASE AGREEMENT"), Premier has agreed to issue to the Secured Party and the
Secured Party has agreed to purchase from Premier an aggregate principal amount
of $4,000,000 of Premier's 6% Secured Convertible Debentures (the "DEBENTURES"),
which are convertible into shares of Premier's Class A Common Stock, no par
value (the "COMMON STOCK"). In connection therewith, Premier shall issue to the
Secured Party Common Stock purchase warrants of even date herewith to purchase
an aggregate of 60,000 shares of Common Stock (the "WARRANTS"); and
WHEREAS, in order to induce the Secured Party to purchase the
Debentures, Premier has agreed to execute and deliver to the Secured Party this
Agreement for the benefit of the Secured Party and to grant to it a first
priority security interest in certain general intangible property of Premier to
secure the prompt payment, performance and discharge in full of all of Premier's
obligations under the Debentures and the exercise and discharge in full of all
of Premier's obligations under the Warrants.
NOW, THEREFORE, in consideration of the agreements herein contained and
for other good and valuable consideration, the receipt and sufficiency of which
is hereby acknowledged, the parties hereto hereby agree as follows:
1. CERTAIN DEFINITIONS. As used in this Agreement, the following terms
shall have the meanings set forth in this Section 1. Terms used but not
otherwise defined in this Agreement that are defined in Article 9 of the UCC
(such as "GENERAL INTANGIBLES" and "PROCEEDS") shall have the respective
meanings given such terms in Article 9 of the UCC.
(a) "CLASS B WARRANTS" means the Company's Class B Warrants,
entitling the holders thereof to purchase an aggregate of 7,592,460 shares of
Common Stock.
(b) "COLLATERAL" means all of the Company's right, title and
interest in and to all of Trademarks, Patents, Copyrights, and other general
intangible property of the Company, all trade secrets, intellectual property
rights in computer software and computer software products, design rights which
may be available to the Company, rights to proceeds arising from any and all
claims for damages by way of past, present and future infringement of any
Collateral with the right but not the obligation to xxx on behalf of and collect
such damages for said use or infringement, licenses to use any of the
Copyrights, Patents or Trademarks, and all license fees and royalties arising
from such use to the extent permitted by such license or rights. The term
"Collateral" shall include all of the foregoing items, whether presently owned
or existing or hereafter acquired or coming into existence, all additions and
accessions thereto, all substitutions and replacements thereof, and all
proceeds, products and accounts thereof, including without limitation all
proceeds from the licensing or sale or other transfer of Collateral and of
insurance covering the same and of any tort claims in connection therewith.
(c) "COMPANY" shall mean, collectively, Premier and all of the
subsidiaries of Premier, other than Ophthalmic Imaging Systems, Inc.
(d) "COPYRIGHTS" means any and all copyrights, copyright
applications, copyright registration and like protections in each work or
authorship and derivative work thereof that is created by the Company, whether
published or unpublished and whether or not the same also constitutes a trade
secret, now or hereafter existing, created, acquired or held, including, without
limitation, those set forth on Exhibit A attached hereto.
(e) "OBLIGATIONS" means all of the Company's obligations under
this Agreement, the Debentures and the Warrants, in each case, whether now or
hereafter existing, voluntary or involuntary, direct or indirect, absolute or
contingent, liquidated or unliquidated, whether or not jointly owed with others,
and whether or not from time to time decreased or extinguished and later
decreased, created or incurred, and all or any portion of such obligations or
liabilities that are paid, to the extent all or any part of such payment is
avoided or recovered directly or indirectly from the Secured Party as a
preference, fraudulent transfer or otherwise as such obligations may be amended,
supplemented, converted, extended or modified from time to time.
(f) "PATENTS" means all of the Company's patents, patent
applications, letters patent and like protections of the United States of
America, including, without limitation, improvements, divisions, continuations,
renewals, reissues, extensions and continuations-in-part of the same, and
including, without limitation, those set forth on EXHIBIT B attached hereto.
(g) "QUALIFIED FACILITY" means a credit facility or factoring
arrangement with a nationally or regionally recognized institutional lender
without conditions or restrictions (including with respect to borrowing base
requirements) as to availability of funds to the Company, whereby such lender
has required the Company to grant to it a first priority security interest in
the Collateral, loans under which facility shall not be subject to repayment for
at least 364 calendar days.
-2-
(h) "QUALIFIED INCOME SOURCE" means any of (i) licensing or
royalty arrangements whereby the Company has received prepaid licensing or
royalty fees, (ii) deposits or prepaid distribution arrangements received by the
Company, (iii) non-refundable net proceeds from the exercise of Class B
Warrants, (iv) non-refundable cash proceeds, net of applicable taxes and other
expenses, from the settlement of or judgment from, any of the litigation
specified in SCHEDULE 1(h) hereto, and (v) a Qualified Facility.
(i) "TRADEMARKS" means any trademark, service xxxx right,
whether or not registered, applications to register and registrations of the
same and like protections, and the entire goodwill of the business of the
Company connected with or symbolized by such trademarks, including, without
limitation, those set forth on Exhibit C attached hereto.
(j) "TWO THIRDS-IN-INTEREST" means one or more of the secured
party signatories hereto holding in excess of 66.66% of the aggregate principal
amount of the Debentures outstanding, determined on a cumulative basis.
(k) "UCC" means the Uniform Commercial Code, as currently in
effect in the State of California.
2. GRANT OF SECURITY INTEREST. As an inducement for the Secured Party
to purchase the Debentures and to secure the complete and timely payment,
performance and discharge in full, as the case may be, of all of the
Obligations, the Company hereby, unconditionally and irrevocably, pledges,
grants and hypothecates to the Secured Party, a continuing security interest in,
a first lien upon and a right of set-off against all of the Company's right,
title and interest of whatsoever kind and nature in and to the Collateral (the
"SECURITY INTEREST").
3. REPRESENTATIONS, WARRANTIES, COVENANTS AND AGREEMENTS OF THE
COMPANY. The Company represents and warrants to, and covenants and agrees with,
the Secured Party as follows:
(a) The Company has the requisite corporate power and
authority to enter into this Agreement and otherwise to carry out its
obligations thereunder. The execution, delivery and performance by the Company
of this Agreement and the filings contemplated therein have been duly authorized
by all necessary action on the part of the Company and no further action is
required by the Company.
(b) Except as specified in SCHEDULE 3(b), the Company is the
sole owner of the Collateral (except for non-exclusive licenses granted by the
Company in the ordinary course of business), free and clear of any liens,
security interests, encumbrances, rights or claims, and is fully authorized to
grant the Security Interest in and to pledge the Collateral. There is not on
file in any governmental or regulatory authority, agency or recording office an
effective financing statement, security agreement, license or transfer or any
notice of any of the foregoing (other than those that have been filed in favor
of the Secured Party pursuant to this Agreement) covering or affecting any of
the Collateral. So long as this Agreement shall be in effect and other than
-3-
pursuant to Section 10 hereof, the Company shall not execute and shall not
knowingly permit to be on file in any such office or agency any such financing
statement or other document or instrument (except to the extent filed or
recorded in favor of the Secured Party pursuant to the terms of this Agreement).
(c) EXHIBIT A sets forth a true and complete list of all
registered Copyrights and any applications thereto in existence as of the date
of this Agreement. EXHIBIT B sets forth a true and complete list of all pending
Patent applications that have been filed and all Patents that have been issued
as of the date of this Agreement. EXHIBIT C sets forth a true and complete list
of all Trademark registered and pending Trademark applications filed, in each
case, in the United States of America as of the date of this Agreement. The
Company shall, within ten (10) days of obtaining knowledge thereof, advise the
Secured Party in writing of any change in the composition of the Collateral,
including, without limitation, any subsequent ownership rights of the Company in
or to any Copyright, Patent or Trademark.
(d) Each of the Patents, Trademarks and Copyrights is valid
and enforceable in the United States of America, and no part of the Collateral
has been judged invalid or unenforceable. There has been no adverse decision to
the Company's claim of ownership rights in or exclusive rights to use the
Collateral in any jurisdiction or to the Company's right to keep and maintain
such Collateral in full force and effect, and, except as set forth in Schedule
3(d) there is no proceeding involving said rights pending or, to the best
knowledge of the Company, threatened before any court, judicial body,
administrative or regulatory agency, arbitrator or other governmental authority.
(e) The Company shall at all times maintain its books of
account and records relating to the Collateral at its principal place of
business and may not relocate such books of account and records unless it
delivers to the Secured Party at least 30 days prior to such relocation (i)
written notice of such relocation and the new location thereof (which must be
within the United States) and (ii) evidence that appropriate financing
statements and other necessary documents have been filed and recorded and other
steps have been taken to perfect the Security Interest to create in favor of the
Secured Party valid, perfected and continuing first priority liens in the
Collateral. The principal place of business of the Company is located at the
address set forth in the introduction to this Agreement.
(f) This Agreement creates in favor of the Secured Party a
valid security interest in the Collateral, including the Collateral listed on
the Exhibits hereto, securing the payment and performance of the Obligations,
and, upon making the filings described in the immediately following sentence, a
perfected first priority security interest in such Collateral. Except for (x)
the filing of this Agreement with the United States Patent and Trademark Office
with respect to the Patents and Trademarks and the filing of this Agreement with
the Register of Copyrights with respect to the Copyrights, and (y) the filing of
financing statements on Form UCC-1 under the UCC with the jurisdictions
indicated in SCHEDULE B, attached hereto, no authorization or approval of or
filing with or notice to any governmental authority or regulatory body located
in the United States of America is required either (i) for the grant by the
Company of, or the effectiveness of, the Security Interest granted hereby or for
the execution, delivery and performance of this Agreement by the Company or (ii)
for the perfection of or exercise by the Secured Party of its rights and
remedies hereunder. The Company acknowledges and agrees that a copy of this
Agreement (or instruments executed and delivered pursuant hereto) will be filed
and recorded with each of the United States Patent and Trademark Office and the
Register of Copyrights with respect to the Patents, Trademarks and Copyrights
that are now or hereafter in existence.
-4-
(g) On the date of execution of this Agreement, the Company
will deliver to the Secured Party (i) one or more executed UCC financing
statements on Form UCC-1 with respect to the Security Interest for filing with
the jurisdictions indicated on SCHEDULE B, attached hereto and in such other
jurisdictions as may be requested by the Secured Party and (ii) one or more
executed recordation sheets relating to the filing and recording of this
Agreement with each of the United States Patent and Trademark Office and the
Register of Copyrights with respect to the Patents, Trademarks and Copyrights
that are now in existence.
(h) The execution, delivery and performance of this Agreement
does not conflict with or cause a breach or default, or an event that with or
without the passage of time or notice, shall constitute a breach or default,
under any agreement to which the Company is a party or by which the Company is
bound. No consent (including, without limitation, from stock holders or
creditors of the Company) is required for the Company to enter into and perform
its obligations hereunder.
(i) The Company shall at all times maintain the liens and
Security Interest provided for hereunder as valid and perfected first priority
(subject to subordination pursuant to Section 10 hereof) liens and security
interests in the Collateral in favor of the Secured Party until this Agreement
and the Security Interest hereunder shall be terminated pursuant to Section 10.
The Company shall safeguard and protect all Collateral for the account of the
Secured Party and the Company hereby agrees to defend the Collateral (provided,
that with respect to the Patents that are included within the definition of
Collateral, such Patents will, for the sole and exclusive purpose of any defense
under this Section 3(i), be limited to the Patents specified on SCHEDULE 3(i))
and the first priority liens and Security Interests created and granted under
this Agreement against any and all persons. At the request of the Secured Party,
the Company will sign and deliver to the Secured Party at any time or from time
to time one or more financing statements pursuant to the UCC (or any other
applicable statute) in form reasonably satisfactory to the Secured Party and
will pay the cost of filing the same in all public offices wherever filing is,
or is deemed by the Secured Party to be, necessary or desirable to effect the
rights and obligations provided for herein. Without limiting the generality of
the foregoing, the Company shall pay all fees, taxes and other amounts necessary
to maintain the Collateral and the Security Interest hereunder, and the Company
shall obtain and furnish to the Secured Party from time to time, upon demand,
such releases and/or subordinations of claims and liens which may be required to
maintain the priority of the Security Interest hereunder. The Patents listed on
SCHEDULE 3(i) are the only Patents that are material to the conduct of the
business of the Company.
(j) Except as permitted by the Purchase Agreement, the Company
will not allow any Collateral to be abandoned, forfeited or dedicated to the
public without the prior written consent of the Secured Party. The Company will
not transfer, pledge, hypothecate, encumber, license (except for non-exclusive
licenses granted by the Company in the ordinary course of business), sell or
otherwise dispose of any of the Collateral without the prior written consent of
the Secured Party.
(k) The Company shall, within ten (10) days of obtaining
knowledge thereof, advise the Secured Party promptly, in sufficient detail, of
any substantial change in the Collateral, and of the occurrence of any event
which would have a material adverse effect on the value of the Collateral or on
the Secured Party's security interest therein.
-5-
(l) The Company shall permit the Secured Party and its
representatives and agents to inspect the Collateral at any time, and to make
copies of records pertaining to the Collateral as may be requested by the
Secured Party from time to time.
(m) The Company will take all steps reasonably necessary to
diligently pursue and seek to preserve, enforce and collect any rights, claims,
causes of action and accounts receivable in respect of the Collateral.
(n) The Company shall promptly notify the Secured Party in
sufficient detail upon becoming aware of any attachment, garnishment, execution
or other legal process levied against any Collateral and of any other
information received by the Company that may materially affect the value of the
Collateral, the Security Interest or the rights and remedies of the Secured
Party hereunder.
(o) All information heretofore, herein or hereafter supplied
to the Secured Party by or on behalf of the Company with respect to the
Collateral is accurate and complete in all material respects as of the date
furnished.
(p) SCHEDULE A, attached hereto contains a list of all of the
subsidiaries of Premier.
4. DEFAULTS. The following events shall be "EVENTS OF DEFAULT":
(a) The occurrence of an Event of Default (as defined in the
Debentures) under the Debentures;
(b) Any representation or warranty of the Company in this
Agreement or in the Security Agreement, dated the date hereof between the
Company and the Secured Party, shall prove to have been incorrect in any
material respect when made;
(c) The failure by the Company to observe or perform any of
its obligations hereunder or in the Security Agreement, dated the date hereof
between the Company and the Secured Party, for ten (10) days after receipt by
the Company of notice of such failure from the Secured Party; and
(d) Any breach or default under the Warrants.
5. DUTY TO HOLD IN TRUST. Upon the occurrence of any Event of Default
and at any time thereafter, the Company shall, upon receipt by it of any
revenue, income or other sums subject to the Security Interest, whether payable
pursuant to the Debentures or otherwise, or of any check, draft, note, trade
acceptance or other instrument evidencing an obligation to pay any such sum,
hold the same in trust for the Secured Party and shall forthwith endorse and
transfer any such sums or instruments, or both, to the Secured Party for
application to the satisfaction of the Obligations.
-6-
6. RIGHTS AND REMEDIES UPON DEFAULT. Upon occurrence of any Event of
Default and at any time thereafter, the Secured Party shall have the right to
exercise all of the remedies conferred hereunder and under the Debentures and
the Warrants, and the Secured Party shall have all the rights and remedies of a
secured party under the UCC and/or any other applicable law (including the
Uniform Commercial Code of any jurisdiction in which any Collateral is then
located). Without limitation, the Secured Party shall have the following rights
and powers:
(a) The Secured Party shall have the right to take possession
of all tangible manifestations or embodiments of the Collateral and, for that
purpose, enter, with the aid and assistance of any person, any premises where
the Collateral, or any part thereof, is or may be placed and remove the same,
and the Company shall assemble the Collateral and make it available to the
Secured Party at places which the Secured Party shall reasonably select, whether
at the Company's premises or elsewhere.
(b) The Secured Party shall have the right to operate the
business of the Company using the Collateral and shall have the right to assign,
sell, or otherwise dispose of and deliver all or any part of the Collateral, at
public or private sale or otherwise, either with or without special conditions
or stipulations, for cash or on credit or for future delivery, in such parcel or
parcels and at such time or times and at such place or places, and upon such
terms and conditions as the Secured Party may deem commercially reasonable, all
without (except as shall be required by applicable statute and cannot be waived)
advertisement or demand upon or notice to the Company or right of redemption of
the Company, which are hereby expressly waived. Upon each such sale, assignment
or other transfer of Collateral, the Secured Party may, unless prohibited by
applicable law which cannot be waived, purchase all or any part of the
Collateral being sold, free from and discharged of all trusts, claims, right of
redemption and equities of the Company, which are hereby waived and released.
(c) The Secured Party may license or, to the same extent the
Company is permitted by law and contract to do so, sublicense, whether on an
exclusive or non-exclusive basis, any of the Collateral throughout the world for
such term, on such conditions and in such manner as the Secured Party shall, in
its sole discretion, determine.
(d) The Secured Party may (without assuming any obligations or
liabilities thereunder), at any time, enforce (and shall have the exclusive
right to enforce) against any licensee or sublicensee all rights and remedies of
the Company in, to and under any license agreement with respect to such
Collateral, and take or refrain from taking any action thereunder.
(e) The Secured Party may, in order to implement the
assignment, license, sale or other disposition of any of the Collateral pursuant
to this Section, pursuant to the authority provided for in Section 11, execute
and deliver on behalf of the Company one or more instruments of assignment of
the Collateral in form suitable for filing, recording or registration in any
jurisdictions as the Secured Party may determine advisable.
7. APPLICATIONS OF PROCEEDS; EXPENSES. (a) The proceeds of any such
sale, lease, license or other disposition of the Collateral hereunder shall be
applied first, to the expenses of retaking, holding, storing, processing and
-7-
preparing for sale, selling, and the like (including, without limitation, any
taxes, fees and other costs incurred in connection therewith) of the Collateral,
to the reasonable attorneys' fees and expenses incurred by the Secured Party in
enforcing its rights hereunder and in connection with collecting, storing and
disposing of the Collateral, and then to satisfaction of the Obligations, and to
the payment of any other amounts required by applicable law, after which the
Secured Party shall pay to the Company any surplus proceeds. If, upon the sale,
license or other disposition of the Collateral, the proceeds thereof are
insufficient to pay all amounts to which the Secured Party is legally entitled,
secured parties signatory hereto will be entitled to their pro rata portion of
such proceeds (determined by reference to the aggregate principal amount of
Debentures outstanding, determined on a cumulative basis), and the Company will
be liable for the deficiency, together with interest thereon, at the rate of 17%
per annum (the "DEFAULT RATE"), and the reasonable fees of any attorneys
employed by the Secured Party to collect such deficiency. To the extent
permitted by applicable law, the Company waives all claims, damages and demands
against the Secured Party arising out of the repossession, removal, retention or
sale of the Collateral, unless due to the gross negligence or willful misconduct
of the Secured Party.
(b) The Company agrees to pay all out-of-pocket fees, costs
and expenses incurred in connection with any filing required hereunder,
including, without limitation, any financing statements, continuation
statements, partial releases and/or termination statements related thereto or
any expenses of any searches reasonably required by the Secured Party. The
Company shall also pay all other claims and charges which in the reasonable
opinion of the Secured Party might prejudice, imperil or otherwise affect the
Collateral or the Security Interest therein. The Company will also, upon demand,
pay to the Secured Party the amount of any and all reasonable expenses,
including the reasonable fees and expenses of its counsel and of any experts and
agents, which the Secured Party may incur in connection with (i) the enforcement
of this Agreement, (ii) the custody or preservation of, or the sale of,
collection from, or other realization upon, any of the Collateral, or (iii) the
exercise or enforcement of any of the rights of the Secured Party under the
Debentures. Until so paid, any fees payable hereunder shall be added to the
principal amount of the Debentures and shall bear interest at the Default Rate.
8. RESPONSIBILITY FOR COLLATERAL. The Company assumes all liabilities
and responsibility in connection with all Collateral, and the obligations of the
Company hereunder or under the Debentures and the Warrants shall in no way be
affected or diminished by reason of the loss, destruction, damage or theft of
any of the Collateral or its unavailability for any reason.
9. SECURITY INTEREST ABSOLUTE. All rights of the Secured Party and all
Obligations of the Company hereunder, shall be absolute and unconditional,
irrespective of: (a) any lack of validity or enforceability of this Agreement,
the Debentures, the Warrants or any agreement entered into in connection with
the foregoing, or any portion hereof or thereof; (b) any change in the time,
manner or place of payment or performance of, or in any other term of, all or
any of the Obligations, or any other amendment or waiver of or any consent to
any departure from the Debentures, the Warrants or any other agreement entered
into in connection with the foregoing; (c) any exchange, release or
nonperfection of any of the Collateral, or any release or amendment or waiver of
or consent to departure from any other collateral for, or any guaranty, or any
other security, for all or any of the Obligations; (d) any action by the Secured
-8-
Party to obtain, adjust, settle and cancel in its sole discretion any insurance
claims or matters made or arising in connection with the Collateral; or (e) any
other circumstance which might otherwise constitute any legal or equitable
defense available to the Company, or a discharge of all or any part of the
Security Interest granted hereby. Until the Obligations shall have been paid and
performed in full, the rights of the Secured Party shall continue even if the
Obligations are barred for any reason, including, without limitation, the
running of the statute of limitations or bankruptcy. The Company expressly
waives presentment, protest, notice of protest, demand, notice of nonpayment and
demand for performance. In the event that at any time any transfer of any
Collateral or any payment received by the Secured Party hereunder shall be
deemed by final order of a court of competent jurisdiction to have been a
voidable preference or fraudulent conveyance under the bankruptcy or insolvency
laws of the United States, or shall be deemed to be otherwise due to any party
other than the Secured Party, then, in any such event, the Company's obligations
hereunder shall survive cancellation of this Agreement, and shall not be
discharged or satisfied by any prior payment thereof and/or cancellation of this
Agreement, but shall remain a valid and binding obligation enforceable in
accordance with the terms and provisions hereof. The Company waives all right to
require the Secured Party to proceed against any other person or to apply any
Collateral which the Secured Party may hold at any time, or to marshal assets,
or to pursue any other remedy. The Company waives any defense arising by reason
of the application of the statute of limitations to any obligation secured
hereby.
10. TERM OF AGREEMENT AND SUBORDINATION OF SECURITY INTEREST. (a) This
Agreement and the Security Interest shall terminate on the earlier of (A)
subject to the provisions of the immediately following sentence, the date of the
receipt by the Secured Party of evidence satisfactory to it that the Company has
received a minimum of $4,000,000 in bona fide funds from a Qualified Income
Source which shall not be subject to repayment prior to the later to occur of
(i) the 364th calendar day following the obtainment of such funds and (ii) the
270th day following the date that an Underlying Shares Registration Statement
(as defined in the Debentures) is first declared effective by the Securities and
Exchange Commission, and (B) the date on which all payments under the Debentures
have been made in full and all other Obligations have been paid or discharged.
Notwithstanding the foregoing and anything to the contrary contained herein, in
no event shall this Agreement or the Security Interest terminate prior to the
date that an Underlying Shares Registration Statement is first declared
effective by the Securities and Exchange Commission.
(b) If the Company shall have entered into a Qualified
Facility for in excess of $500,000, then the Security Interest shall, subject to
terms mutually acceptable to the Company and the Secured Party, become
subordinate to any security interest granted to such lender pursuant to such
Qualified Facility.
(c) Upon any termination or subordination of the Security
Interest pursuant to this Section 10, the Secured Party, at the request and at
the expense of the Company, will join in executing an appropriate amendment or
termination statement (as the case may be) with respect to any financing
statement executed and filed pursuant to this Agreement.
11. POWER OF ATTORNEY; FURTHER ASSURANCES. (a) The Company authorizes
the Secured Party, and does hereby make, constitute and appoint it, and its
respective officers, agents, successors or assigns with full power of
substitution, as the Company's true and lawful attorney-in-fact, with power, in
-9-
its own name or in the name of the Company, to, after the occurrence and during
the continuance of an Event of Default, (i) endorse any notes, checks, drafts,
money orders, or other instruments of payment (including payments payable under
or in respect of any policy of insurance) in respect of the Collateral that may
come into possession of the Secured Party; (ii) to sign and endorse any UCC
financing statement or any invoice, freight or express xxxx, xxxx of lading,
storage or warehouse receipts, drafts against debtors, assignments,
verifications and notices in connection with accounts, and other documents
relating to the Collateral; (iii) to pay or discharge taxes, liens, security
interests or other encumbrances at any time levied or placed on or threatened
against the Collateral; (iv) to demand, collect, receipt for, compromise, settle
and xxx for monies due in respect of the Collateral; and (v) generally, to do,
at the option of the Secured Party, and at the Company's expense, at any time,
or from time to time, all acts and things which the Secured Party deems
necessary to protect, preserve and realize upon the Collateral and the Security
Interest granted therein in order to effect the intent of this Agreement, the
Debentures and the Warrants, all as fully and effectually as the Company might
or could do; and the Company hereby ratifies all that said attorney shall
lawfully do or cause to be done by virtue hereof. This power of attorney is
coupled with an interest and shall be irrevocable for the term of this Agreement
and thereafter as long as any of the Obligations shall be outstanding.
(b) On a continuing basis, the Company will make, execute,
acknowledge, deliver, file and record, as the case may be, in the proper filing
and recording places in any jurisdiction, including, without limitation, the
jurisdictions indicated on Schedule B, attached hereto, all such instruments,
including appropriate financing and continuation statements and collateral
agreements and filings with the United States Patent and Trademark Office and
the Register of Copyrights, and take all such action as may reasonably be deemed
necessary or advisable, or as reasonably requested by the Secured Party, to
perfect the Security Interest granted hereunder and otherwise to carry out the
intent and purposes of this Agreement, or for assuring and confirming to the
Secured Party the grant or perfection of a security interest in all the
Collateral.
(c) The Company hereby irrevocably appoints the Secured Party
as the Company's attorney-in-fact, with full authority in the place and stead of
the Company and in the name of the Company, from time to time in the Secured
Party's discretion, to take any action and to execute any instrument which the
Secured Party may deem necessary or advisable to accomplish the purposes of this
Agreement, including:
(i) To modify, in its sole discretion, this Agreement
without first obtaining the Company's approval of or signature to such
modification by amending EXHIBIT A, EXHIBIT B AND EXHIBIT C, hereof, as
appropriate, to include reference to any right, title or interest in any
Copyrights, Patents or Trademarks acquired by the Company after the execution
hereof or to delete any reference to any right, title or interest in any
Copyrights, Patents or Trademarks in which the Company no longer has or claims
any right, title or interest; and
(ii) To file, in its sole discretion, one or more
financing or continuation statements and amendments thereto, relative to any of
the Collateral without the signature of the Company where permitted by law.
-10-
12. NOTICES. All notices, requests, demands and other communications
hereunder shall be in writing, with copies to all the other parties hereto, and
shall be deemed to have been duly given when (i) if delivered by hand, upon
receipt, (ii) if sent by facsimile, upon receipt of proof of sending thereof,
(iii) if sent by nationally recognized overnight delivery service (receipt
requested), the next business day or (iv) if mailed by first-class registered or
certified mail, return receipt requested, postage prepaid, four days after
posting in the U.S. mails, in each case if delivered to the following addresses:
If to the Company: Premier Laser Systems, Inc.
0 Xxxxxx
Xxxxxx, XX 00000
Facsimile No.: (000) 000-0000
Attn: Chief Financial Officer
With copies to: Xxxxx & Xxxxxx LLP
000 Xxxxx Xxxxxxxxx, 00xx xxxxx
Xxxxx Xxxx, XX 00000-0000
Facsimile No.: (000) 000-0000
Attn: Xxxxxx X. Xxxxxxxxxxx, Esq.
If to the Secured Party to the address for notice set forth below such
Secured Party's name on the signature page hereto.
13. OTHER SECURITY. To the extent that the Obligations are now or
hereafter secured by property other than the Collateral or by the guarantee,
endorsement or property of any other person, firm, corporation or other entity,
then the Secured Party shall have the right, in its sole discretion, to pursue,
relinquish, subordinate, modify or take any other action with respect thereto,
without in any way modifying or affecting any of the Secured Party's rights and
remedies hereunder.
14. ACTIONS BY THE SECURED PARTY. Any action required or permitted
hereunder to be taken by or on behalf of the secured parties signatory hereto
shall, for such action to be valid, require the approval of the Two
Thirds-in-Interest prior to the taking of such action. If the consent, approval
or disapproval of the secured parties signatory hereto is required or permitted
pursuant to this Agreement, such consent, approval or disapproval shall only be
valid if given by the Two Thirds-in-Interest.
15. MISCELLANEOUS.
(a) No course of dealing between the Company and the Secured
Party, nor any failure to exercise, nor any delay in exercising, on the part of
the Secured Party, any right, power or privilege hereunder or under the
Debentures shall operate as a waiver thereof; nor shall any single or partial
exercise of any right, power or privilege hereunder or thereunder preclude any
other or further exercise thereof or the exercise of any other right, power or
privilege.
-11-
(b) All of the rights and remedies of the Secured Party with
respect to the Collateral, whether established hereby or by the Debentures or by
any other agreements, instruments or documents or by law shall be cumulative and
may be exercised singly or concurrently.
(c) This Agreement constitutes the entire agreement of the
parties with respect to the subject matter hereof and is intended to supersede
all prior negotiations, understandings and agreements with respect thereto.
Except as specifically set forth in this Agreement, no provision of this
Agreement may be modified or amended except by a written agreement specifically
referring to this Agreement and signed by the parties hereto.
(d) In the event that any provision of this Agreement is held
to be invalid, prohibited or unenforceable in any jurisdiction for any reason,
unless such provision is narrowed by judicial construction, this Agreement
shall, as to such jurisdiction, be construed as if such invalid, prohibited or
unenforceable provision had been more narrowly drawn so as not to be invalid,
prohibited or unenforceable. If, notwithstanding the foregoing, any provision of
this Agreement is held to be invalid, prohibited or unenforceable in any
jurisdiction, such provision, as to such jurisdiction, shall be ineffective to
the extent of such invalidity, prohibition or unenforceability without
invalidating the remaining portion of such provision or the other provisions of
this Agreement and without affecting the validity or enforceability of such
provision or the other provisions of this Agreement in any other jurisdiction.
(e) No waiver of any breach or default or any right under this
Agreement shall be considered valid unless in writing and signed by the party
giving such waiver, and no such waiver shall be deemed a waiver of any
subsequent breach or default or right, whether of the same or similar nature or
otherwise.
(f) This Agreement shall be binding upon and inure to the
benefit of each party hereto and its successors and assigns.
(g) Each party shall take such further action and execute and
deliver such further documents as may be necessary or appropriate in order to
carry out the provisions and purposes of this Agreement.
(h) This Agreement shall be construed in accordance with the
laws of the State of New York, except to the extent the validity, perfection or
enforcement of a security interest hereunder in respect of any particular
Collateral which are governed by a jurisdiction other than the State of New York
in which case such law shall govern. Each of the parties hereto irrevocably
submit to the exclusive jurisdiction of any New York State or United States
Federal court sitting in Manhattan county over any action or proceeding arising
out of or relating to this Agreement, and the parties hereto hereby irrevocably
agree that all claims in respect of such action or proceeding may be heard and
determined in such New York State or Federal court. The parties hereto agree
that a final judgment in any such action or proceeding shall be conclusive and
may be enforced in other jurisdictions by suit on the judgment or in any other
manner provided by law. The parties hereto further waive any objection to venue
in the State of New York and any objection to an action or proceeding in the
State of New York on the basis of forum non convenient.
-12-
(i) EACH PARTY HERETO HEREBY AGREES TO WAIVE ITS RESPECTIVE
RIGHTS TO A JURY TRIAL OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT
OF THIS AGREEMENT. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING
OF ANY DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT
MATTER OF THIS AGREEMENT, INCLUDING WITHOUT LIMITATION CONTRACT CLAIMS, TORT
CLAIMS, BREACH OF DUTY CLAIMS AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS.
EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT FOR
EACH PARTY TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH PARTY HAS ALREADY
RELIED ON THIS WAIVER IN ENTERING INTO THIS AGREEMENT AND THAT EACH PARTY WILL
CONTINUE TO RELY ON THIS WAIVER IN THEIR RELATED FUTURE DEALINGS. EACH PARTY
FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS WAIVER WITH ITS LEGAL
COUNSEL, AND THAT SUCH PARTY HAS KNOWINGLY AND VOLUNTARILY WAIVED ITS RIGHTS TO
A JURY TRIAL FOLLOWING SUCH CONSULTATION. THIS WAIVER IS IRREVOCABLE, MEANING
THAT, NOTWITHSTANDING ANYTHING HEREIN TO THE CONTRARY, IT MAY NOT BE MODIFIED
EITHER ORALLY OR IN WRITING, AND THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT
AMENDMENTS, RENEWALS AND SUPPLEMENTS OR MODIFICATIONS TO THIS AGREEMENT. IN THE
EVENT OF A LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A
TRIAL BY THE COURT.
(j) This Agreement may be executed in any number of
counterparts, each of which when so executed shall be deemed to be an original
and, all of which taken together shall constitute one and the same Agreement. In
the event that any signature is delivered by facsimile transmission, such
signature shall create a valid binding obligation of the party executing (or on
whose behalf such signature is executed) the same with the same force and effect
as if such facsimile signature were the original thereof.
* * * * * * * * * * *
-13-
IN WITNESS WHEREOF, the parties hereto have caused this
Intellectual Property Security Agreement to be duly executed on the day and year
first above written.
PREMIER LASER SYSTEMS, INC.
By: /S/ XXXXXXX XXXXXX
---------------------------------
Name: Xxxxxxx Xxxxxx
Title: CEO
SECURED PARTY:
STRONG RIVER INVESTMENTS, INC.
By: /S/ XXXXXXX X. XXXXXXXXX
---------------------------------
Xxxxxxx X. Xxxxxxxxx
Attorney-in-Fact
Address for Notice:
Strong River Investments, Inc.
c/x Xxxxxxx Capital Corp.
000 Xxxxx Xxxxxx, Xxxxx 0000
Xxx Xxxx, XX 00000
Facsimile No.: (000) 000-0000
Attn: Avi Vigder
HERKIMER LLC
By: /S/ L. FAMINGTON /S/ XXXXXX XXXXXXX
------------------------------------
Name: CT Corporation Ltd.
Title: Director
Address for Notice:
x/x Xxxxx Xxxxxxxx (Xxxxxx) Limited
Commercial Centre
P.O. Box 31106 SMB
Grand Cayman
Cayman Islands
British West Indies
Facsimile No.: (000) 000-0000
-14-
with a copy to: Southridge Capital Management LLC
Executive Pavillon
00 Xxxxx Xxxxxx
Xxxxxxxxxx, XX 00000
Facsimile No.: (000) 000-0000
With copies for
communications to
Secured Party to: Xxxxxxxx Xxxxxxxxx Xxxxxx Xxxxxxxx &
Xxxxxx LLP
0000 Xxxxxx xx xxx Xxxxxxxx
Xxx Xxxx, XX 00000
Facsimile No.: (000) 000-0000
Attn: Xxxxxxx X. Xxxxxxxxx, Esq.
Xxxx X. Xxxxx. Esq.
EXHIBIT A to Intellectual Property Security Agreement
Copyright Registrations and Applications Therefor
None
STATUS REPORT FOR PREMLS U.S. ISSUED PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001FW1 MEDICAL LASER INTERCONNECT SYSTEM USA ISSUED 07/568549 08/16/90 5116329 05/26/92
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.002W1 FILBER OPTIC APPARATUS FOR USE WITH USA ISSUED 07/803919 12/06/91 5207673 05/04/93
MEDICAL LASERS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.009FW4 TRANSPARENT LASER SURGICAL PROBE USA ISSUED 08/419511 04/07/95 5688261 11/18/97
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.011FW4 CONTACT TIP FOR LASER SURGERY USA ISSUED 08/457992 06/01/95 5707368 01/13/98
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.013A OPTICS FOR MEDICAL LASER USA ISSUED 07/644074 01/18/91 5198926 03/30/93
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.013DV1 OPTICS FOR MEDICAL LASER USA ISSUED 08/021354 02/23/93 5289557 02/22/94
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018DV1 MULTIWAVELENGTH MEDICAL LASER USA ISSUED 07/917589 07/17/92 5304167 04/19/94
METHOD
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018FW2 MULTIWAVELENGTH MEDICAL LASER USA ISSUED 07/754327 09/04/91 5139494 08/18/92
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018FW4 METHOD OF LASER SURGERY USING USA ISSUED 08/422648 04/14/95 5540676 07/30/96
MULTIPLE WAVELENGTHS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.024FW1 MEDICAL LASER APPARATUS FOR USA ISSUED 08/075720 06/11/93 5349590 09/20/94
DELIVERING HIGH POWER INFRARED
LIGHT
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.031FW2 CORNEAL SCULPTING USING LASER USA ISSUED 08/384243 02/06/95 5741245 04/21/98
ENERGY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033DV1 APPARATUS AND METHOD FOR USA ISSUED 08/455732 05/31/95 5738677 04/14/98
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.046A LASER SURGICAL METHOD USA ISSUED 07/763350 09/20/91 5267856 12/07/93
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050A HIGH REPETITION RATE MID-INFRARED USA ISSUED 08/240255 05/10/94 5422899 06/06/95
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.052A METHOD AND APPARATUS FOR USA ISSUED 972531 11/06/92 5300065 04/05/94
SIMULTANEOUSLY HOLDING AND
SEALING TISSUE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.053A METHOD AND APPARATUS FOR APPLYING USA ISSUED 972532 11/06/92 5290278 03/01/94
THERMAL ENERGY TO LUMINAL TISSUE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.055FW3 LASER SURGICAL METHOD USING USA ISSUED 08/391612 02/21/95 5722970 03/03/98
TRANSPARENT PROBE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.0556A METHOD AND APPARATUS FOR APPLYING USA ISSUED 972530 11/06/92 5336221 08/09/94
THERMAL ENERGY TO TISSUE USING A
CLAMP
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.059A OPTICAL HEATING SYSTEM USA ISSUED 997554 12/28/92 5354323 10/11/94
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.060A METHOD AND APPARATUS FOR SEALING USA ISSUED 981197 11/25/92 5364389 11/15/94
AND/OR GRASPING LUMINAL TISSUE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.063A LASER SURGICAL PROCEDURES FOR USA ISSUED 08/633670 04/17/96 5865831 02/02/99
TREATMENT OF GLAUCOMA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.075A LASER HEALING METHOD USA ISSUED 06/539527 10/06/83 4672969 06/16/87
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.076A LASER HEALING METHOD AND USA ISSUED 07/062861 06/16/87 4854320 08/08/89
APPARATUS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.077A METHOD FOR CLOSING TISSUE WOUNDS USA ISSUED 07/380622 07/14/89 5002051 03/26/91
USING RADIATIVE ENERGY BEAMS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.078A LASER HEALING METHOD AND USA ISSUED 07/639025 01/09/91 5140984 08/25/92
APPARATUS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.079A METHOD FOR CLOSING TISSUE WOUNDS USA ISSUED 07/934167 08/24/92 5409479 04/25/95
USING RADIATIVE ENERGY BEAMS
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135A METHOD AND APPARATUS FOR USA ISSUED 08/279506 07/22/94 5520631 05/28/96
LOWERING THE INTRAOCULAR PRESSURE
OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135CP1 METHOD AND APPARATUS FOR USA ISSUED 08/570400 12/11/95 5704907 01/06/98
LOWERING THE INTRAOCULAR PRESSURE
OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136A METHOD FOR SURGICALLY RE-PROFILING USA ISSUED 07/450672 12/14/89 5063942 11/12/91
THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136CP1 METHOD FOR SURGICALLY RE-PROFILING USA ISSUED 07/762866 09/18/91 5318044 06/07/94
THE CORNEA TO CORRECT FOR
HYPEROPIA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136CP3 METHOD AND APPARATUS FOR RE- USA ISSUED 08/345245 11/28/94 5591185 01/07/97
PROFILING OR SMOOTHING THE
ANTERIOR OR STROMAL CORNEA USING
SCRAPING
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136CPF2 METHOD AND APPARATUS FOR USA ISSUED 08/170679 12/20/93 5368604 11/29/94
SURGICALLY PROFILING THE CORNEA
USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136DC1 APPARATUS FOR SURGICALLY RE- USA ISSUED 07/979424 11/19/92 5395385 03/07/95
PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
STATUS REPORT FOR PREMLS U.S. PENDING PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.009DV1 LASER SURGICAL PROBE USA PENDING 08/841865 05/05/97
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.011DV1 CONTACT TIP FOR LASER SURGERY USA PENDING 08/455061 05/31/95
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.049FW2 DENTAL LASER SURGERY APPARATUS USA PENDING 08/882362 06/25/97
AND METHOD
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050DFC1 HIGH REPETITION RATE MID-INFRARED USA PENDING 08/979213 11/26/97
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050DV2 HIGH REPETITION RATE MID-INFRARED USA PENDING 08/931600 09/17/97
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.063DV1 LASER SURGICAL PROCEDURES FOR USA PENDING 09/169258 10/09/98
TREATMENT OF GLAUCOMA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.112A OPTICAL SOURCE AND METHOD USA PENDING 05/03/99
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135CP2 METHOD AND APPARATUS FOR USA PENDING 08/998875 12/24/97
LOWERING THE INTRAOCULAR PRESSURE
OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.146A OCCULAR FUNDUS CAMERA USA PENDING 09/186710 11/05/98
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.31FDV1 CORNEAL SCULPTING USING LASER USA PENDING 08/455899 05/31/95
ENERGY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.33F3C1 APPARATUS AND METHOD FOR USA PENDING 09/018373 02/04/98
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
STATUS REPORT FOR PREMLS FOREIGN ISSUED PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VAU MEDICAL LASER INTERCONNECT SYSTEM AUSAL ISSUED 43601/89 10/19/89 612910 12/03/91
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VCA MEDICAL LASER INTERCONNECT SYSTEM CANAD ISSUED 2000916 10/18/89 2000916 01/17/95
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VEP MEDICAL LASER INTERCONNECT SYSTEM EPO ISSUED 89310520.5 10/13/89 0365228 12/14/94
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VNO MEDICAL LASER INTERCONNECT SYSTEM NORW ISSUED 894170 10/19/89 178842 06/19/96
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VPT MEDICAL LASER INTERCONNECT SYSTEM PORTG ISSUED 92021 10/18/89 92021 10/09/95
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.002VAU FIBER OPTIC APPARATUS FOR USE WITH AUSAL ISSUED 56921/90 06/07/90 613560 12/11/91
MEDICAL LASERS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.002VCA FIBER OPTIC APPARATUS FOR USE WITH CANAD ISSUED 2018450 06/07/90 2018450 05/09/95
MEDICAL LASERS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.002VKR FIBER OPTIC APPARATUS FOR USE WITH KORSO ISSUED 90-7829 05/30/90 55974 11/02/92
MEDICAL LASERS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018VAU MULTIWAVELENGTH MEDICAL LASER AUSAL ISSUED 44520/89 11/09/89 626339 02/01/93
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018VCA MULTIWAVELENGTH MEDICAL LASER CANAD ISSUED 2002453 11/08/89 2002453 01/17/95
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018VPT MULTIWAVELENGTH MEDICAL LASER PORTG ISSUED 92240 11/09/89 92240 05/03/95
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033RAU APPARATUS AND METHOD FOR AUSAL ISSUED 28572/97 04/01/93 699994 04/01/99
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033VAU APPARATUS AND METHOD FOR AUSAL ISSUED 40486/93 04/01/93 678967 10/09/97
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050VAU HIGH REPETITION RATE MID-INFRARED AUSAL ISSUED 17964/95 05/09/95 685593 05/07/98
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050VEP HIGH REPETITION RATE MID-INFRARED EPO ISSUED 95302891.7 04/28/95 0682389 09/02/98
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050VIL HIGH PULSE REPETITION AND ITS USE ISREA ISSUED 113501 04/26/95 113501 05/19/97
(AMENDED TITLE)
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.053QAU METHOD AND APPARATUS FOR APPLYING AUSAL ISSUED 53643/94 10/19/93 684054 03/26/98
THERMAL ENERGY TO LUMINAL TISSUE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.056VAU CLAMP AND METHOD FOR APPLYING AUSAL ISSUED 53607/94 10/14/93 682324 01/22/98
THERMAL ENERGY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.060VAU METHOD AND APPARATUS FOR SEALING AUSAL ISSUED 56699/94 11/16/93 684057 03/26/98
LUMINAL TISSUE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136HEP APPARATUS FOR SURGICALLY PROFILING EPO ISSUED 91920409.9 09/16/91 0551439 08/09/95
THE CORNEA USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136HMX APPARATUS FOR SURGICALLY PROFILING MEXIC ISSUED 911426 10/03/91 177228 03/15/95
THE CORNEA USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136HZA METHOD AND APPARATUS FOR SOFRC ISSUED 91/7835 10/01/91 91/7835 08/26/92
SURGICALLY PROFILING THE CORNEA
USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136QEP APPARATUS FOR RE-PROFILING THE EPO ISSUED 92920651.4 09/17/92 0680298 01/21/98
CORNEA TO CORRECT FOR HYPEROPIA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136QMX METHOD AND APPARATUS FOR RE- MEXIC ISSUED 925239 09/14/92 178296 06/07/95
PROFILING THE CORNEA TO CORRECT
FOR HYPEROPIA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VCN APPARATUS FOR SURGICALLY RE- CHINA ISSUED 90110433.7 12/14/90 42198 07/24/98
PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VKR APPARATUS FOR RE-PROFILING THE KORSO ISSUED 92-701415 12/12/90 156727 07/23/98
CORNEA
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VMX APPARATUS FOR SURGICALLY RE- MEXIC ISSUED 23746 12/14/90 167844 04/15/93
PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VRU METHOD AND APPARATUS FOR RUSSA ISSUED 5052732 12/12/90 2094032 10/27/97
SURGICALLY RE-PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VZA METHOD AND APPARATUS FOR SOFRC ISSUED 90/10063 12/14/90 90/10063 11/27/91
SURGICALLY RE-PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
STATUS REPORT FOR PREMLS PENDING FOREIGN PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VDK MEDICAL LASER INTERCONNECT SYSTEM DENMR PENDING 5185/89 10/19/89
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VF1 MEDICAL LASER INTERCONNECT SYSTEM FINLN PENDING 894978 10/19/89
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VJE MEDICAL LASER INTERCONNECT SYSTEM IRELN PENDING 3351/89 10/18/89
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.001VJP1 MEDICAL LASER INTERCONNECT SYSTEM JAPAN PENDING 282818/89 10/30/89
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.002VJP FIBER OPTIC APPARATUS FOR USE WITH JAPAN PENDING 151431/90 06/08/90
MEDICAL LASERS
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.009QCA LASER SURGICAL PROBE CANAD PENDING 2107687 04/03/92
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.009QEP LASER SURGICAL PROBE EPO PENDING 92910340.6 04/03/92
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018VIE MULTIWAVELENGTH MEDICAL LASER IRELN PENDING 3594/89 11/08/89
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.018VJP MULTIWAVELENGTH MEDICAL LASER JAPAN PENDING 292115/89 11/09/89
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.031VEP CORNEAL SCULPTING USING LASER EPO PENDING 93903487.2 01/14/93
ENERGY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.031VJP CORNEAL SCULPTING USING LASER JAPAN PENDING 513266/1993 01/14/93
ENERGY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033VCA APPARATUS AND METHOD FOR CANAD PENDING 2117765 04/01/93
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033VEP APPARATUS AND METHOD FOR EPO PENDING 93911621.6 04/01/93
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033VJP APPARATUS AND METHOD FOR JAPAN PENDING 518505/1993 04/01/93
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.033VKR APPARATUS AND METHOD FOR KORSO PENDING 94-703632 04/01/93
PERFORMING EYE SURGERY
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050RAU HIGH REPETITION RATE MID-INFRARED AUSAL PENDING 63510/98 05/09/95
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050VCA HIGH REPETITION RATE MID-INFRARED CANAD PENDING 2148395 05/02/95
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050VJP PULSED OPTICALLY PUMPED LASER AND JAPAN PENDING 110517/1995 05/09/95
SURGICAL METHOD USING THE SAME
(AMENDED TITLE)
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.050VKR HIGH REPETITION RATE MID-INFRARED KORSO PENDING 11234/1995 05/09/95
LASER
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135QAU APPARATUS FOR LOWERING THE AUSAL PENDING 58782/96 05/24/96
INTRAOCULAR PRESSURE OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135QCA APPARATUS FOR LOWERING THE CANAD PENDING 2240146 05/24/96
INTRAOCULAR PRESSURE OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135QEP APPARATUS FOR LOWERING THE EPO PENDING 96920501.2 05/24/96
INTRAOCULAR PRESSURE OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135QJP APPARATUS FOR LOWERING THE JAPAN PENDING 522009/1997 05/24/96
INTRAOCULAR PRESSURE OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.135QKR APPARATUS FOR LOWERING THE KORSO PENDING 98-704394 05/24/96
INTRAOCULAR PRESSURE OF AN EYE
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136HCA METHOD AND APPARATUS FOR CANAD PENDING 2092285 09/16/91
SURGICALLY PROFILING THE CORNEA
USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136HCN METHOD AND APPARATUS FOR CHINA PENDING 91109274.9 10/03/91
SURGICALLY PROFILING THE CORNEA
USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136HJP METHOD AND APPARATUS FOR JAPAN PENDING 518532/1991 09/16/91
SURGICALLY PROFILING THE CORNEA
USING VACUUM
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136QCA METHOD AND APPARATUS FOR RE- CANAD PENDING 2119365 09/17/92
PROFILING THE CORNEA TO CORRECT
FOR HYPEROPIA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136QCN METHOD AND APPARATUS FOR RE- CHINA PENDING 92110484.7 09/18/92
PROFILING THE CORNEA TO CORRECT
FOR HYPEROPIA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136QOP METHOD AND APPARATUS FOR RE- JAPAN PENDING 506213/1993 09/17/92
PROFILING THE CORNEA TO CORRECT
FOR HYPEROPIA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VBR METHOD AND APPARATUS FOR RE- BRAZL PENDING P19007915-9 12/12/90
PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VCA METHOD AND APPARATUS FOR RE- CANAD PENDING 2071853 12/12/90
PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VEP METHOD FOR SURGICALLY RE-PROFILING EPO PENDING 91902435.6 12/12/90
THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
PREMLS.136VJP METHOD AND APPARATUS FOR RE- JAPAN PENDING 502814/1991 12/12/90
PROFILING THE CORNEA
------------------------------------------------------------------------------------------------------------------------------------
STATUS REPORT FOR EYESYS FOREIGN ISSUED PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.017XBX ABSOLUTE SCALE FOR CORNEAL BENLX ISSUED 68088-0 10/08/92 23121-00 04/21/93
TOPOGRAPHY
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.017XDE ABSOLUTE SCALE FOR CORNEAL XXXXX ISSUED M9207467.7 10/09/92 M9207467.7 02/03/93
TOPOGRAPHY
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.017XFR ABSOLUTE SCALE FOR CORNEAL FRANC ISSUED 926338 10/09/92 0322610 12/31/92
TOPOGRAPHY
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.017XGB ABSOLUTE SCALE FOR CORNEAL UNIKN ISSUED 2026301 10/15/92 2026301 12/08/93
TOPOGRAPHY
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.017XJP ABSOLUTE SCALE FOR CORNEAL JAPAN ISSUED 29897/1992 10/12/92 925512 03/09/95
TOPOGRAPHY
------------------------------------------------------------------------------------------------------------------------------------
STATUS REPORT FOR EYESYS U.S. ISSUED PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.018A METHOD AND APPARATUS FOR VARIABLE USA ISSUED 08/044401 04/08/93 5418714 05/23/95
BLOCK SIZE INTERPOLATIVE CODING OF
IMAGES
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.020FW1 METHOD OF REFRACTIVE SURGERY USA ISSUED 08/355436 12/13/94 5722427 03/03/98
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.021FW1 MULTI-CAMERA CORNEAL ANALYSIS USA ISSUED 08/638875 04/25/96 5847804 12/08/98
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.13CPCP1 METHOD OF CORNEAL ANALYSIS USING A USA ISSUED 08/736348 10/23/96 5841511 11/24/98
CHECKERED XXXXXXX APPARATUS
------------------------------------------------------------------------------------------------------------------------------------
STATUS REPORT FOR EYESYS U.S. PENDING PATENTS
------------------------------------------------------------------------------------------------------------------------------------
Application Filing Patent Issue
Case Number Title of Invention Country Status Number Date Number Date
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.008A HANDHELD CORNEAL TOPOGRAPHY USA PENDING 09/001339 12/31/97
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.020FICI METHOD OF REFRACTIVE SURGERY USA PENDING 08/956878 10/23/97
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.021FICI MULTI-CAMERA CORNEAL ANALYSIS USA PENDING 08/956515 10/23/97
SYSTEM
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.030A METHOD AND APPARATUS FOR USA PENDING 08/060826 05/10/93
PREDICTING CORNEAL ACUITY
------------------------------------------------------------------------------------------------------------------------------------
EYESYS.13CPCPC METHOD OF CORNEAL ANALYSIS USING A USA PENDING 09/102839 06/23/98
CHECKERED XXXXXXX APPARATUS
------------------------------------------------------------------------------------------------------------------------------------
SCHEDULE B TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
Jurisdictions where UCC-1 filings required
------------------------------------------
1. California Secretary of State
SCHEDULE 1(h) TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
Premier Laser Systems vs. Infrared Fiber Systems, Inc., Coherent, Inc., et
al., as described in Item 3 to Annual Report on Form 10-K of Premier Laser
Systems for the fiscal year ended March 31, 1998.
SCHEDULE 3(b) TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
Ownership of Collateral
-----------------------
1. Under Agreement dated January 9, 1998 with Corneal Contouring
Development LLC ("CCD"), PLS may be obligated to return technology
relating to a corneal reprofiling device, if certain conditions are not
met. This device is not presently marketed by PLS. CCD has a security
interest in the assets pertaining to this product.
2. Under Agreement dated August 28, 1998 with Wound Healing of Oklahoma,
Inc., PLS may be obligated to return technology relating to a device
for lowering the intraocular pressure of the eye, if certain conditions
are not met. This device is not presently marketed by PLS.
3. Under a Technology Transfer and Software License Agreement dated
October 16, 1998 among Premier Laser Systems, Inc., Xxxxxx and
Associates, Inc. and Xxxxx Xxxxxx, PLS may be required to return
technology relating to mapping of the eye. This device is not presently
marketed by PLS.
4. Joint ownership of patent for laser tip, with Xxxxxxx Xxxxxxx.
SCHEDULE 3(d) TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
CURRENT MATTERS
1. BRITESMILE, INC., A UTAH CORPORATION, PLAINTIFF V. INTERDENT, INC., A
CALIFORNIA CORPORATION, PREMIER LASER SYSTEMS, INC., A CALIFORNIA
CORPORATION. This is a patent infringement case filed 09/22/97
regarding a laser method for bleaching teeth.
2. Opposition against Premier Laser Systems application in the Patent and
Trademark Office to registration of the trademark "Aurora", and
objection to the further use of that name by Premier Laser Systems in
connection with the sale of its products.
OLD MATTERS WHICH MAY NO LONGER BE IN DISPUTE
3. Xx. Xxxxxxxxx: Letter alleging that he is an inventor of certain
(unspecified) technology of Premier Laser.
4. Dr. Xxxxxxxx Bath: Letter alleging that Premier infringes a patent.
5. Opticon: Letter alleging that Premier infringes a patent.
6. Xx. Xxxxxxxxxx: Letter alleging that Premier infringes copyright.
7. Dr. Berlin: Letter to his lawyer (not to Premier) alleging that
Premier infringes a patent.
SCHEDULE 3(i) TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
List of Material Patents
EXHIBIT B TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
List of Patents
SCHEDULE A - FOREIGN TRADEMARK APPLICATIONS AND REGISTRATIONS
------------------------------------------------------------------------------------------------------------------------
COUNTRY Xxxx App. No. Reg. No. Class(es) Status
App. Date Reg. Date
------------------------------------------------------------------------------------------------------------------------
Australia ARAGO 771079 10 Pending.
08/21/98
------------------------------------------------------------------------------------------------------------------------
Australia ORION 771080 10 Pending.
08/21/98
------------------------------------------------------------------------------------------------------------------------
Xxxxxxxxx XXXXXX 000000 10 Pending.
08/21/98
------------------------------------------------------------------------------------------------------------------------
Australia POLARIS 771082 771082 10 Registered.
08/21/98 04/06/99
------------------------------------------------------------------------------------------------------------------------
Australia ALTAIR 771083 771083 10 Registered.
08/21/98 04/06/99
------------------------------------------------------------------------------------------------------------------------
Australia AURORA 771084 771084 10 Registered.
08/21/98 04/06/99
------------------------------------------------------------------------------------------------------------------------
Australia CENTAURI 771085 10 Pending.
08/21/98
------------------------------------------------------------------------------------------------------------------------
Australia PEGASUS 771086 10 Pending.
08/21/98
------------------------------------------------------------------------------------------------------------------------
Australia DERMIUM 774012 774012 10 Registered.
09/23/98 02/12/99
------------------------------------------------------------------------------------------------------------------------
Brazil ARAGO 821022784 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil ORION 821022776 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil SIRIUS 821022768 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil POLARIS 821022733 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil ALTAIR 821022741 10 Pending.
08/29/98
------------------------------------------------------------------------------------------------------------------------
Brazil AURORA 821022750 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil CENTAURI 821022806 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil PEGASUS 821022792 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
Brazil DERMIUM 821088777 10 Pending.
08/26/98
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
COUNTRY Xxxx App. No. Reg. No. Class(es) Status
------------------------------------------------------------------------------------------------------------------------
Canada ARAGO 888187 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada ORION 888188 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Xxxxxx XXXXXX 000000 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada POLARIS 888190 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada ALTAIR 888191 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada AURORA 888192 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada CENTAURI 888193 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada PEGASUS 888194 9, 10, 35 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Canada DERMIUM 890293 10 Pending.
099/15/98
------------------------------------------------------------------------------------------------------------------------
European ARAGO 913657 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European ORION 913764 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European SIRIUS 913897 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European POLARIS 913723 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European ALTAIR 913632 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European AURORA 913798 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European CENTAURI 913749 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European PEGASUS 913822 9, 10, 35 Pending.
Community 08/28/98
------------------------------------------------------------------------------------------------------------------------
European DERMIUM 958553 10 Pending.
Community 09/18/98
------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------
COUNTRY Xxxx App. No. Reg. No. Class(es) Status
------------------------------------------------------------------------------------------------------------------------
Japan ARAGO 072418/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan ORION 072419/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan SIRIUS 072420/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan POLARIS 072421/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan ALTAIR 072422/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan AURORA 072423/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan CENTAURI 072424/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan PEGASUS 072425/1998 10 Pending.
08/24/98
------------------------------------------------------------------------------------------------------------------------
Japan DERMIUM 079934/1998 10 Pending.
09/16/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXXXXX 00-00000 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
South Korea PEGASUS 98-23701 10 Pending.
09/12/98
------------------------------------------------------------------------------------------------------------------------
Xxxxx Xxxxx XXXXXXX 00-00000 10 Pending.
09/16/98
------------------------------------------------------------------------------------------------------------------------
EXHIBIT C TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
Trademarks
SCHEDULE A TO INTELLECTUAL PROPERTY SECURITY AGREEMENT
Subsidiaries
------------
1. EyeSys - Premier, Inc., a Delaware corporation
100% owned
2. CRS U.S.A., Inc., a California mutual benefit nonprofit corporation
(Premier Laser Systems, Inc. is the sole member)
3. Xxxx.Xxxx, LLC, a California limited liability company
(51% owned by Premier Laser Systems, Inc., now in the process of being
shut down)
4. Ophthalmic Imaging Systems, a California corporation (51% owned by
Premier Laser Systems, Inc.)
Schedule B - U.S. Federal Trademark Applications
-----------------------------------------------------------------------------------------------------
XXXX APP. NO. REG. NO. CLASS(ES) Status
APP. DATE REG. DATE
-----------------------------------------------------------------------------------------------------
ARAGO 75/307,008 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
ORION 75/307,502 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
SIRIUS 75/307,537 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
POLARIS 75/307,518 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
TOUCHTIPS 75/307,510 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
ANGLETIPS 75/307,503 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
ALTAIR 75/307,001 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
AURORA 75/307,276 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
CENTAURI 75/307,520 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
PEGASUS 75/307,155 9, 10 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
PREMIER LASER 75/307,501 9, 10 Pending.
SYSTEMS, INC. 06/11/97
-----------------------------------------------------------------------------------------------------
PREMIER 75/307,511 9 Pending.
06/11/97
-----------------------------------------------------------------------------------------------------
THE SAFE 75/307,517 2,176,685 10 Registered.
SYSTEM 06/11/97 07/28/98
-----------------------------------------------------------------------------------------------------
PROCLOSURE 74/289,453 1,817,399 10 Registered.
06/29/92 01/18/94
-----------------------------------------------------------------------------------------------------
LTM 74/284,041 1,832,072 10 Registered.
02/20/92 04/19/94
-----------------------------------------------------------------------------------------------------
DENTISTRY FOR 75/318,632 10 Pending.
THE 21ST 07/02/97
CENTURY
-----------------------------------------------------------------------------------------------------
PREMIER LASER 75/418,320 9, 10 Pending.
08/25/97
-----------------------------------------------------------------------------------------------------
DERMIUM 75/458,345 10 Pending.
03/27/98
-----------------------------------------------------------------------------------------------------
CELLPLANT 75/315,007 10 Pending.
06/26/97
-----------------------------------------------------------------------------------------------------
-----------------------------------------------------------------------------------------------------
XXXX App. No. Reg. No. Class(es) Status
-----------------------------------------------------------------------------------------------------
DENTISTRY FOR 75/550,091 Pending.
THE 21ST 09/08/98
CENTURY
-----------------------------------------------------------------------------------------------------
MEDICINE FOR 75/550,084 Pending.
THE 21ST 09/08/98
CENTURY
-----------------------------------------------------------------------------------------------------
Schedule C - U.S. Federal Eyesys Trademark Registrations
-----------------------------------------------------------------------------------------------------------------
Registration Registration
XXXX Number Date Class(es) Status
-----------------------------------------------------------------------------------------------------------------
PRO-FIT 2,136,132 02/10/98 9 Registered
-----------------------------------------------------------------------------------------------------------------
EYESYS 1,789,249 08/24/93 9, 10 Registered
-----------------------------------------------------------------------------------------------------------------
TOMORROW'S VISION 1,788,833 08/17/93 9, 10 Registered
TODAY
-----------------------------------------------------------------------------------------------------------------
TITLE OF INVENTION COUNTRY PATENT NUMBER
------------------ ------- -------------
Medical Laser Interconnect System USA 5116329
Medical Laser Interconnect System AUSAL 612910
Medical Laser Interconnect System CANAD 2000916
Medical Laser Interconnect System EPO 0365228
Laser Surgical Method USA 5267856
Method for Surgically Re-Profiling the Cornea USA 5063942
Method for Surgically Re-Profiling the Cornea to USA 5318044
Correct For Hyperopia
Apparatus for Re-Profiling the Cornea to EPO 0680298
Correct for Hyperopia
Method and Apparatus for Surgically USA 5368604
Profiling the Cornea
Apparatus for Surgically Profiling the EPO 0551439
Cornea Using Vacuum
Apparatus for Surgically Re-Profiling the USA 5395385
Cornea
Method and Apparatus for Reprofiling or USA 5591185
Smoothing the Anterior or Stromal Cornea
Using Scraping
Laser Healing Method USA 4672969
Laser Healing Method and Apparatus USA 4854320
Method for Closing Tissue Wounds Using USA 5002051
Radiative Energy Beams
Laser Healing Method and Apparatus USA 5140984
Method for Closing Tissue Wounds Using USA 5409479
Radiative Energy Beams
Optical Heating System USA 5354323
Method and Apparatus for Lowering the USA 5520631
Intraocular Pressure of an Eye
Method and Apparatus for Lowering the USA 5704907
Intraocular Pressure of an Eye
Title of Invention Country Patent Number
------------------ ------- -------------
Laser Surgical Procedures for Treatment of USA 5865831
Glaucoma
Apparatus and Method for Performing Eye USA 5738677
Surgery
Apparatus and Method for Performing Eye AUSAL 699994
Surgery
Apparatus and Method for Performing Eye AUSAL 678967
Surgery
Laser Surgical Method Using Transparent USA 5722970
Probe
Transparent Laser Surgical Probe USA 5688261
High Repetition Rate Mid-Infrared Laser USA 5422899
High Repetition Rate Mid-Infrared Laser AUSAL 685593
High Repetition Rate Mid-Infrared Laser EPO 0682389
High Pulse Repetition and Its Use ISREA 113501
(Amended Title)
Multiwavelength Medical Laser Method USA 5304167
Multiwavelength Medical Laser System USA 5139494
Method of Laser Surgery Using Multiple USA 5540676
Wavelengths
Multiwavelength Medical Laser System AUSAL 626339
Multiwavelength Medical Laser System CANAD 2002453
Multiwavelength Medical Laser System PORTG 92240
Corneal Sculpting Using Laser Energy USA 5741245
Multi-Camera Corneal Analysis System USA 5847804
